Korean J Physiol Pharmacol.
2024 Jul;28(4):389-389. 10.4196/kjpp.2024.28.4.389.
Corrigendum to: Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe
- Affiliations
-
- 1Department of Zoology, Faculty of Science, Al-Azhar University, Cairo 11651, Egypt
- 2Department of Zoology, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
- 3Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
- 4Department of Pharmaceutics, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt
- KMID: 2557210
- DOI: http://doi.org/10.4196/kjpp.2024.28.4.389
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe
- Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)
- Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)
- Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
- Ultrasound-guided drug delivery in cancer
